Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

Roche plans to modernize its capital structure, seeking shareholder approval at the 2026 AGM. Non-voting equity securities ("Genussscheine") will be exchanged for participation certificates, each valued at CHF 0.001. The nominal value of bearer shares will be reduced from CHF 1 to CHF 0.001 to ensure equal treatment. Bearer shareholders will receive CHF 0.999 per share as repayment of nominal value. Participation certificates will be listed on the SIX Swiss Exchange, maintaining dividend and liquidation rights. Roche will discontinue printed dividend vouchers, transitioning to intermediated securities. Home custodians are urged to convert printed certificates to intermediated securities to ensure smooth dividend payments. No new printed certificates for bearer shares or participation certificates will be issued. Detailed information and FAQs are available for further clarification. Roche aims to improve healthcare through innovative medicines and diagnostics.